XML 42 R5.htm IDEA: XBRL DOCUMENT v3.20.1
Shareholders Equity (Unaudited) - USD ($)
Common Stock
Additional Paid-In Capital
Retained Earnings / Accumulated Deficit
Total
Beginning Balance at Dec. 31, 2018 $ 5,883 $ 60,523,901 $ (48,125,349) $ 12,404,435
Beginning Balance (in shares) at Dec. 31, 2018 5,883,109      
Restricted stock grants 116 (116)   116,050
Restricted stock grants (in shares) $ 116,050      
Stock-based compensation   $ 121,965   $ 121,965
Net gain (loss)     11,839 11,839
Ending Balance at Mar. 31, 2019 $ 5,999 60,645,750 (48,113,510) 12,538,239
Ending Balance (in shares) at Mar. 31, 2019 5,999,159      
Beginning Balance at Dec. 31, 2019 $ 6,018 61,066,971 (47,838,763) $ 13,234,226
Beginning Balance (in shares) at Dec. 31, 2019 6,017,674      
Restricted stock grants       287,000
Repurchase of common stock $ (5) (8,491)   $ 8,496
Repurchase of common stock (in shares) (4,967)      
Cancellation of restricted stocks $ (3) 3    
Cancellation of restricted stocks (in shares) (3,200)      
Stock-based compensation   132,055   132,055
Net gain (loss)     (90,327) (90,327)
Ending Balance at Mar. 31, 2020 $ 6,010 $ 61,190,548 $ (47,929,090) $ 13,267,468
Ending Balance (in shares) at Mar. 31, 2020 6,009,507